Capitalizing on Galectin-1-Glycan Interactions for the Design of Novel Therapeutic Strategies in Inflammatory Bowel Diseases.

Prospective Double-Blind Diet Controlled Trial of Low Carbohydrate Diets in Pediatric Crohn’s Disease.

The Impact of Fermentable Carbohydrate Restriction (Low FODMAP Diet) on Functional Gut Symptoms, Gut Microbiota and Immunology in Patients With Crohn’s Disease.

Exploring The Therapeutic Potential Of MUC2, A Gut-Specific Mucin With Anti-Inflammatory Properties.

Targeting Calpain-Induced Cleavage Of HMGB1 Client Proteins To Restore Intestinal And Metabolic Homeostasis In Inflammatory Bowel Diseases.

Novel Adhesive Interactions Modulate T Cell Responses In IBD.

From Newborn Immunity To Adult IBD.

The Role Of Long Non-Coding RNA, LincRNA-Eps In Controlling Gut Inflammation.

Dysbiotic Intervention: Harnessing Intrinsic Human Defenses Via The Paneth Cell Secretome To Engineer The Microbiome.

Immunity-Related GTPases: A New Network Hub Model For IBD.